AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Danavish Healthcare

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

Danavish Glibenclamide/Metformin 5mg/500mg extended-release tablets are antidiabetic medications combining two drugs to manage type 2 diabetes in adults. This combination helps regulate blood glucose. Administer these tablets with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may adjust based on blood sugar monitoring. Continue taking this medication even if feeling well, as discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan incorporating diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat it. Maintain regular meals and carry a fast-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Disclose any history of heart disease to your doctor before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

There is no text provided to rephrase.

Uses of Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Danavish Glibenclamide+Metformin 5mg/500mg SR tablet whole; do not break, crush, or chew it. Administer this medication with food.

Common Side effects of Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with food.

How Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR works:

Danavish SR tablets, containing 5mg Glibenclamide and 500mg Metformin, offer a dual-action approach to diabetes management by combining these two established antidiabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Danavish Glibenclamide+Metformin 5mg/500mg SR tablets with alcohol is hazardous.

PregnancyPregnancySAFE IF PRESCRIBED

The extended-release Danavish Glibenclamide/Metformin 5mg/500mg tablet is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nonetheless, clinical data from human studies remain scarce.

Breast feedingBreast feedingCAUTION

The extended-release Danavish Glibenclamide+Metformin 5mg/500mg tablet requires careful consideration when breastfeeding. Lactation should be suspended throughout the mother's treatment and until the medication is fully cleared from her system.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability may be affected by Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR, though this is unconfirmed. Refrain from driving if concentration or reaction time is impaired by any side effects.

KidneyKidneyUNSAFE

The combination drug Danavish Glibenclamide+Metformin 5mg/500mg SR tablet is likely contraindicated for individuals with impaired renal function and should be avoided. Seek medical advice from your physician.

LiverLiverCAUTION

Patients with liver impairment should use Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician before use. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in patients with severe liver dysfunction.

What if you forget to take Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR :

Should you forget a Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Danavish Glibenclamide+Metformin 5mg/500mg Tablet SR

Danavish Glibenclamide/Metformin 5mg/500mg SR tablets combine glibenclamide and metformin to manage type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's unsuitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize existing insulin effectively. This leads to elevated blood glucose, causing serious health issues. High blood sugar symptoms include excessive urination, thirst, and hunger. Untreated, diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased risk of heart disease.
Danavish Glibenclamide+Metformin 5mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach upset, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Danavish Glibenclamide+Metformin 5mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Danavish Glibenclamide+Metformin 5mg/500mg SR tablets can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may manifest as anemia, nerve damage (including tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Danavish Glibenclamide+Metformin 5mg/500mg SR Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Danavish Glibenclamide+Metformin 5mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication safely and ensure it's inaccessible to children, pets, and others.
Danavish Glibenclamide+Me...
16
MRP 18
11% off